or Try an Advanced Search...

    Technical Analysis for SONN - SONNET BioTherapeutics, Inc.

    Grade Last Price % Change Price Change
    F 2.92 -3.95% -0.12
    SONN closed down 3.95 percent on Wednesday, November 20, 2024, on 20 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: Dec 12
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical SONN trend table...
    Date Alert Name Type % Chg
    Boomer Buy Setup Bullish Swing Setup 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.95%
    Inside Day Range Contraction -3.95%
    Wide Bands Range Expansion -3.95%
    Oversold Stochastic Weakness -3.95%
    New 52 Week Closing Low Bearish 2.46%
    Reversal New Lows Setup Bearish Swing Setup 2.46%
    Older End-of-Day Signals for SONN ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 17 hours ago
    Up 5% about 17 hours ago
    Up 3% about 17 hours ago
    Down 2 % about 17 hours ago
    Down 1% about 17 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    SONN Chart by TradingView
    Basic chart:

    Profile

    SONNET BioTherapeutics, Inc. is a biotechnology company that engages in development of bi and tri functional therapies that can simulate or block immune-modulating targets to control cancer. The company uses albumin binding single chain antibody fragment (scFv) for delivery of recombinant human-cytokines (rH-cytokines) and other validated targets. SONNET BioTherapeutics, Inc. was incorporated in 2015 and is based in Princeton, New Jersey.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Biology Immunology Antibody Cytokine Blood Plasma Biochemistry

    Is SONN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 12 Sonnet BioTherapeutics Releases Virtual Investor ‘”What this Means” Segment
    Nov 6 Sonnet BioTherapeutics Announces Pricing of $5.0 Million Underwritten Public Offering Priced At-The-Market Under Nasdaq Rules
    Nov 6 Gold Down Over 2%; CVS Health Shares Jump After Q3 Results
    Nov 6 Dow Jumps Over 1,200 Points; Donald Trump Wins White House
    Nov 6 Sonnet BioTherapeutics Announces Issuance of U.S. Patent Covering a Variant IL-18 Incorporated into Two Novel Immunotherapeutic Drug Candidates
    Oct 28 Sonnet stock tumbles 22% in wake of proposed offering filing
    Oct 10 Sonnet BioTherapeutics’ Strategic Deal to Develop DPN Treatment
    Oct 4 Sonnet BioTherapeutics to Receive Non-Dilutive Funding Through New Jersey Tax Certificate Transfer and Australia R&D Tax Incentive Programs
    Sep 30 Sonnet BioTherapeutics Announces Launch of CEO Corner Platform
    Sep 25 Sonnet BioTherapeutics to execute 1-for-8 reverse stock split
    See more SONN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 18.7192
    52 Week Low 2.5
    Average Volume 564,153
    200-Day Moving Average 9.84
    50-Day Moving Average 5.20
    20-Day Moving Average 3.94
    10-Day Moving Average 3.13
    Average True Range 0.73
    RSI (14) 27.01
    ADX 32.77
    +DI 33.29
    -DI 18.02
    Chandelier Exit (Long, 3 ATRs) 7.84
    Chandelier Exit (Short, 3 ATRs) 4.68
    Upper Bollinger Bands 5.90
    Lower Bollinger Band 1.97
    Percent B (%b) 0.24
    BandWidth 99.87
    MACD Line -0.69
    MACD Signal Line -0.64
    MACD Histogram -0.044
    Fundamentals Value
    Market Cap 8.96 Million
    Num Shares 3.07 Million
    EPS -18.14
    Price-to-Earnings (P/E) Ratio -0.16
    Price-to-Sales 29.80
    Price-to-Book 19.07
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.43
    Resistance 3 (R3) 3.47 3.33 3.35
    Resistance 2 (R2) 3.33 3.20 3.32 3.32
    Resistance 1 (R1) 3.13 3.12 3.06 3.09 3.29
    Pivot Point 2.99 2.99 2.96 2.98 2.99
    Support 1 (S1) 2.79 2.86 2.72 2.75 2.55
    Support 2 (S2) 2.65 2.78 2.64 2.52
    Support 3 (S3) 2.45 2.65 2.50
    Support 4 (S4) 2.41